Such mRNA-modified T cells (STAREGFR-T cells) have been analyzed for anti-EGFR bispecific TCE secretion and for their ability to drive anti-tumor responses against EGFR-expressing cells, both in vitro and in vivo. Here, EGFR is linked to neoplasm.